Comments on the CY 2027 OPPS and ASC Proposed Rule (CMS-1850-P)
AMMA’s response to CMS on whether Medicare outpatient payment should recognize hospitals that buy American-made PPE and essential medicines.
Read the response →Resources
Written Submission on Revoking China’s PNTR Status (Investigation No. 332-609)
Submitted to the U.S. International Trade Commission on the effects of revoking China’s Permanent Normal Trade Relations status.
Read the response →Comments on Section 301 Investigations: Structural Excess Capacity (USTR-2026-0067)
AMMA on excess capacity and production in manufacturing sectors, and what it does to American medical manufacturers.
Read the response →Comments on Section 301 Investigations: Forced Labor (USTR-2026-0133)
Domestic capacity, and the national-security, market and human-rights risks in overseas PPE supply chains, filed with the U.S. Trade Representative.
Read the response →Comments on Made in America PPE and Essential Medicine Procurement (CMS-1516-ANPRM)
What a workable domestic standard looks like: how origin should be defined, how purchases can be verified, and how payment should reflect the cost of domestic sourcing.
Read the response →Get the newsletter in your inbox
Read past issues here, or subscribe to receive the AMMA Newsletter each month.